Psyence Biomedical Ltd. PBM
5.56
(0.30)
(5.12%)
as of 25 Sep
- Market cap
- $22.4M
- P/E
- 0.2×
Follow PBM
| Older periods | Mar '24 | Sep '24 | Mar '25 | Sep '25 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | (189.96%) | 0.00% | (23.52%) | |
| 0.00% | (2.74%) | 0.00% | (15.37%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 20.36% | 0.00% | (14.70%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | (1,125.07) | — | (34.08) | |
Free Cash Flow |
(5.33) | (6.30) | — | (8.08) | |
Piotroski F-Score |
— | 1.00 | — | 1.00 | |
| Other line items | |||||
Cash ROIC |
52.25% | (891.15%) | 0.00% | (42.37%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | 0.00 | — | 0.00 | |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | — | 0.00% | |
Operating CF/Net income |
0.00 | 24.66 | — | 8.21 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
— | 0.00 | — | 0.00 | |
Operating CF per Share |
0.00 | (1,125.07) | — | (34.08) | |
Capex per Share |
— | 0.00 | — | 0.00 | |
Net Profit Margin |
— | 0.00% | — | 0.00% |
Columns are period end dates